KLRS

Kalaris Therapeutics

75 hedge funds and large institutions have $600M invested in Kalaris Therapeutics in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.24M
Puts
$44K
Net Calls
Net Calls Change

Top Buyers

1 +$18.9M
2 +$18.2M
3 +$13.1M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$11.5M
5
Goldman Sachs
Goldman Sachs
New York
+$5.85M

Top Sellers

1 -$8.94M
2 -$5.12M
3 -$4.1M
4
First Trust Advisors
First Trust Advisors
Illinois
-$2.61M
5
Norges Bank
Norges Bank
Norway
-$1.92M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$163M
2
$55.5M
3
$54.4M
4
$51.1M
5
$45.5M
6
$36.6M
7
$27.6M
8
$25.7M
9
$25.7M
10
$14.4M
11
$11.7M
12
$10.5M
13
$10M
14
$7.68M
15
$6.82M
16
$6.56M
17
$3.58M
18
$3.35M
19
$2.92M
20
$2.76M
21
$2.33M
22
$2.22M
23
$2.19M
24
$1.97M
25
$1.93M